Clinical Trials in Egypt / NCT04499898
Recruiting
Phase 2/3
Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding
NCT04499898 · tracked via the Priya Life Science Egypt tracker
Condition(s) studied
Esophageal Varices
Investigational drug(s) / intervention(s)
Carvedilol →Endoscopic band ligation
Carvedilol: Carvedilol
Endoscopic band ligation: Endoscopic band ligation
Study summary
Carvedilol versus endoscopic band ligation for primary prophylaxis of oesophageal variceal bleeding in cirrhotic patients with arterial hypertension
Eligibility
Inclusion Criteria:
* • Aged \>18 years
* Cirrhotic patients with arterial hypertension
* Endoscopic evidence of medium/large-sized esophageal varices
Exclusion Criteria:
* • History of variceal bleeding or previous primary prevention of varices.
* Portal vein thrombosis or previous porto-systemic shunts as TIPS.
* Patients on drugs affecting portal pressure (beta blockers, nitrates).
* Advanced cardiovascular disease including acute myocardial infarction, atrio-ventricular block, congestive heart failure, chronic peripheral ischemia, severe bradycardia.
* Patients with severe respiratory diseases (COPD, bronchial asthma).
* Uncontrolled diabetes mellitus
* Renal impairment
* Hepatocellular carcinoma
* Allergy to carvedilol
* Pregnancy or lactation
Primary outcome measure(s)
- Number of patients with the first variceal bleeding within 1 year — 1 year
The number of patients with the first variceal bleeding within 1 year
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Sherief Abd-Elsalam | Tanta | Egypt | Recruiting |
On this site
📄 Coreg (carvedilol) drug profile →More Sherief Abd-Elsalam trials in Egypt
Statins and ARBs on Rheumatoid Activity
Recruiting
Effect of Some Drugs on Liver Fibrosis
Recruiting
Role of Bumetanide in Treatment of Autism
Recruiting
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04499898 on ClinicalTrials.gov ↗ ← All trials in Egypt